H Toplak Selected Research

Atherosclerosis

5/2014

[New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Toplak Research Topics

Disease

3	Body Weight (Weight, Body) 01/2007 - 12/2001
3	Weight Loss (Weight Reduction) 01/2007 - 12/2001
2	Peripheral Arterial Occlusive Disease 1 09/2000 - 01/2000
2	Venous Thrombosis (Deep-Vein Thrombosis) 07/2000 - 01/2000
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2020
1	Atherosclerosis 05/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2000

Drug/Important Bio-Agent (IBA)

2	factor V LeidenIBA 07/2000 - 01/2000
2	Factor V (Coagulation Factor V)IBA 07/2000 - 01/2000
2	Prothrombin (Factor II)IBA 07/2000 - 01/2000
1	Testosterone (Sustanon)FDA Link 01/2020
1	LipidsIBA 05/2014
1	CholesterolIBA 05/2014
1	Topiramate (Topamax)FDA LinkGeneric 01/2007
1	Metformin (Glucophage)FDA LinkGeneric 01/2007
1	Orlistat (Xenical)FDA Link 11/2005
1	Acarbose FDA LinkGeneric 12/2001
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 09/2000
1	Factor XIII (Coagulation Factor XIII)IBA 07/2000
1	Blood Coagulation Factors (Coagulation Factor)IBA 07/2000

Therapy/Procedure

1	Glycemic Control 01/2007
1	Caloric Restriction 12/2001